GLPwatch

Mixing Pens and the Future of Diabetes Drugs.

J Diabetes Sci Technol · 2015

Last updated 2026-05-28
JournalJ Diabetes Sci Technol, 2015
Citations2
Relative citation ratio0.08
NIH percentile6
Molecules
Conditions studied Type 2 Diabetes

Abstract

With the availability of a smaller mixing pen, mass marketing of less stable medications is possible. Bidureon is one such medication, and the properties of its pen are discussed along with the prospects for future mixing pens.

Verbatim abstract via PubMed 25944896 ↗